Dr. Lesser enjoys tennis, opera, swimming, sailing, history and travel. He and his lovely wife have three wonderful children and five extraordinary grandchildren.

Robert L. Lesser MD

Dr. Lesser obtained his medical degree from Weill Cornell University Medical College and his Bachelor of Science degree from Queens College, City University of New York. He completed his ophthalmology residency at Yale University in the Department of Ophthalmology and Visual Science and did additional training in Neuro-Ophthalmology at the Bascom Palmer Eye Institute in Miami, Florida. He is a Clinical Professor of Ophthalmology and Visual Science and Neurology at Yale and Clinical Professor of Neurology and Neurosurgery at the University of Connecticut School of Medicine.

Dr. Lesser was on the editorial board of the Journal of Neuro-Ophthalmology and is the former Chief of Neuro-Ophthalmology at Yale. He is a recipient of the American Academy of Ophthalmology Honor and Senior Honor Award and has been listed in many different publications as one of the “Best Doctors in America.” He has written and published many articles and textbook chapters and continues to speak at various meetings across the country. Dr. Lesser is a fellow of the North American Neuro-Ophthalmology Society, the American Academy of Ophthalmology and former president of Yale Alumni in Ophthalmology. He has received the Excellence in Clinical Teaching Award from the Department of Ophthalmology and Visual Science at Yale four separate times.

Publications:

1. Kaufman P., Lesser R.L., Wynder E. “Short Term Follow-up Study on Ex-Cigarette Smoker.” American Rev. Respiratory Disease, 96:645-655, 1967.
2. Lesser R.L., Smith J.L., Susac J., Abramson D. “Vertical Ocular Dysmetria.” American Journal of Ophthalmology, 76:206-311, 1973.
3. VanGilder J.C., Allen W.E., Lesser R.L. “Pontine Abscess: Survival Following Surgical Drainage.” Journal of Neurosurgery, 40:386-390, March 1974.
4. Lesser R.L., Jampol L.M. “Tolosa-Hunt Syndrome and Anti-Nuclear Factor.” American Journal of Ophthalmology, 77:732-734, May 1974.
5. Howard R.O., Breg W.R., Albert D.M., Lesser R.L. “Retinoblastoma and Chromosome Abnormality – Partial Deletion of the Long Arm Chromosome 13.” Archives of Ophthalmology, 96:490-493, December 1974.
6. Albert D.M., Lahav M., Lesser R.L., Craft J. “Recent Observations Regarding Retinoblastoma.” Transcripts of Ophthalmological Society of the United Kingdom, 94:Part IV, 1974.
7. Lesser R.L., Smith J.L., Susac J., Abramson D. “Vertical Ocular Dysmetria.” A reprint, by invitation in Clinical Studies in Ophthalmology: Strabismus and Amblyopia, published by Publishing Sciences Group, Inc., Acton, Massachusetts, September 1975.
8. Mason G., Peyman G., Jampol L.M., Lesser R.L. “Staphyloma: A Complication of Surgery for Hyphema.” Journal of Pediatric Ophthalmology and Strabismus, 15(6):386-391, November/December 1978.
9. Lesser R.L., Albert D.M., Bobowick A.R., O’Brien F.H. “Creutzfeldt-Jakob Disease and Optic Atrophy.” American Journal of Ophthalmology, 87:317-321, 1979 March.
10. Lesser R.L., Simon R.M., Leon H., Siegel N. “Cryptococcal Meningitis and Internal Ophthalmoplegia.” American Journal of Ophthalmology, 87:682-687, 1979.
11. Albert D.M., Lesser R.L., Cykiert R.C., Zakov Z.N. “Orbito-facial Mucormycosis with Unusual Pathological Features.” British Journal of Ophthalmology, 63(10):699-703, 1979 Oct.
12. Heinemann M.H., Soloway S.M., Lesser R.L. “Cogan’s Syndrome.” Annals of Ophthalmology, 12(6):331-339, 1980 June.
13. Lesser R.L., Geehr R., Higgins D.D., Greenberg A.D. “Ocular Motor Paralysis and Arachnoid Cyst.” Archives of Ophthalmology, 98:1993-1995, 1980 Nov.
14. Lesser R.L., Heinemann M.H., Borkowski F.A., Cohen L.S. “Mitral Valve Prolapse and Amaurosis Fugax.” Journal of Clinical Neuro-Ophthalmology, 11:153-160, 1981 June.
15. Caprioli J., Lesser R.L. “Basal Encephalocele and Morning Glory Syndrome.” British Journal of Ophthalmology, 67:349-351, 1983 June.
16. Caprioli J., Lesser R.L. “Acute Monocular Visual Loss Secondary to Anterior Communicating Artery Aneurysm a Patient with Sickle Cell Disease.” Annals of Ophthalmology, 15:873-876, 1983 Sept.
17. Lesser R.L. “Creutzfeldt-Jakob Disease.” Current Ocular Therapy 2, Philadelphia, W. B. Saunders Company, Page 175, 1984.
18. Lesser R.L. “Neuro-Ophthalmic Aspects of Pituitary Disease.” The Pituitary: Clinical Aspects of Normal and Abnormal Function, Amsterdam-New York-Oxford. I Goodrich and K. J. Lee, 67-85, 1987.
19. Hufnagel T.J., Lesser R.L., Miller J.M., Abrahams J.J., Piepmeier J., Manuelidis E.E. “Malignant Glioma of the Optic Chiasm Eight Years After Radiotherapy for Prolactinoma.” Archives of Ophthalmology, 106:1701-1705, 1988 Dec.
20. Gray R.S., Abrahams J.J., Hufnagel T.J., Kim J.H., Lesser R.L., Spencer D.D. “Ghost-Cell Tumor of the Optic Chiasm.” Primary CNS Lymphoma, 9(2):98-104, 1989 July.
21. Kornmehl E.W., Lesser R.L., Jaros P., Rocco E., Steere A. “Bilateral Keratitis in Lyme Disease.” Ophthalmology, 96(8):1194-1197, 1989 Aug.
22. Katz L.J., Lesser R.L., Merikangas J.R., Silverman J.P. “Ocular Myasthenia Gravis After D-Penicillamine Administration.” British Journal of Ophthalmology, 73(12):1015-1018, 1989 Dec.
23. Lesser R.L. “Follow-Up of Ocular Tumors.” Follow-Up of Cancer, Third Edition, David S. Fischer, Page 21, 1990.
24. Lesser R.L. “Creutzfeldt-Jakob Disease.” Current Ocular Therapy, Third Edition, Philadelphia, W. B. Saunders Company, Frederick Fraunfelder and F. Hampton Roy, 247-248, 1990.
25. Lesser R.L., Zheutlin J.D., Boghen D., Odel J.G., Robbins R.J. “Visual Function Improvement in Patients with Macroprolactinomas Treated with Bromocriptine.” American Journal of Ophthalmology, 109:535-543, 1990 May.
26. Lesser R.L., Kornmehl E.W., Pachner A.R., Kattah J., Hedges T.R., Newman N.M., Ecker P.A., Glassman M.I. “Neuro-Ophthalmologic Manifestations of Lyme Disease.” Ophthalmology, 97(6):699-706, 1990 June.
27. Lesser R.L., Berger B. “Oculocutaneous Manifestations of Lyme Disease.” Dermatologic Clinics, Philadelphia, Pennsylvania, W. B. Saunders Company; Rothe, M. J., Kels, Barry D., Grant-Kels, J. M. (Eds), Lyme Disease, 1992 Oct.
28. Cooper M.L., Lesser R.L. “Prolonged Course of Bilateral Acute Idiopathic Blind Spot Enlargement.” Journal of Clinical Neuro-Ophthalmology, 12(3):173-177, 1992.
29. Lesser R.L. “Creutzfeldt Jakob Disease.” Current Ocular Therapy, Fourth Edition, Philadelphia, W. B. Saunders Company, Fraunfelder, R. And Roy, R. H., 1994.
30. Weinberg D., Lesser R.L., Vollmer T. “Ocular Myasthenia: A Protean Disorder.” Survey of Ophthalmology, 39(3):169-210, 1994 Nov-Dec.
31. Lesser R.L. “Ocular Manifestations of Lyme Disease.” American Journal of Medicine, Lyme Disease Supplement, 98:60-62, 1995 April.
32. DeLuise V., Lesser R.L., Scrimenti D. “Ocular and Dermatologic Findings in Lyme Disease.” Eye and Skin Disease, Chapter 63, 551-560. Lippincott-Raven Publishers, Mark J. Mannis, M.D., ed.; 1995.
33. Lesser R.L., Sugin S.L., Brodie S.E. “Mastocytosis Induced Nyctalopia.” Journal of Neuro-Ophthalmology, 16(2):115-119, 1996.
34. Finelli P., Lesser R.L. “Neuro-Ophthalmic Presentation of Non-Hodgkin’s Lymphoma.” Neurology, 48(3):784-785, 1997 March.
35. Lesser R.L. “Spirochetes and the Spirochetoses.” Walsh & Hoyt’s Clinical Neuro-Ophthalmology, Fifth Edition, Chapter 67, Volume 4. Williams & Wilkins, publishers; 1998.
36. Lesser R.L., Kornmehl E. “Lyme Disease.” Duane’s Foundations of Clinical Ophthalmology, Volume 5, Chapter 75, Editor: Tasman, William, Publisher: Lippincott Williams & Wilkins, 1998.
37. Lesser R.L. “Creutzfeldt-Jakob Disease.” Current Ocular Therapy, Fifth Edition, 1998. Editors: Fraunfelder, F. T., Roy, H. Publisher: W. B. Saunders Company.
38. Levin L.A., Beck R.W., et al. “The Treatment of Optic Neuropathy, International Optic Nerve Trauma Study.’ Ophthalmology, 1999.
39. Huna-Baron R., Lesser R.L., Warren F.W., Muszynski C.A., Kupersmith M.J. “Infantile Cerebral Aneurysms with Visual Pathway Compression.” Pediatric Neurosurgery, 31:322-325, 1999.
40. Boghen D.R., Lesser R.L. “Blepharospasm and Hemifacial Spasm.” Current Treatment Options in Neurology, 2:393-399, 2000.
41. Jacobs L.D., Beck R.W., et al and the CHAMPS’ Study Group. “Intramuscular Interferon Beta 1 Therapy Initiated During a First Demyelinating Event in Multiple Sclerosis.” New England Journal of Medicine, 898-904, 2000 Sept.
42. Parsa C.F., Hoyt C.S., Lesser R.L., Weinstein J.M. et al. Spontaneous Regression of Optic Gliomas. Archives of Ophthalmology, 119:516-529, 2001 April.
43. Lesser R.L., Boghen D. “Diagnosis and Management of Pituitary Adenoma.” American Academy of Ophthalmology Focal Points, XIX(8), 2001 Sept.
44. Jacobs D.A., Lesser R.L., Mourelatos Z., Galetta S.L., Balcer L.J. “The Heidenhain Variant of Creutzfeldt-Jakob Disease: Clinical, Pathologic, and Neuroimaging Findings.” Journal of Neuro-Ophthalmology, 21(2):99-102, 2001.
45. Tomohiro I., Spaide R.F., Haas A., Yannuzzi L.A., Jampol L.M., Lesser R.L. “Leopard-Spot Pattern of Yellowish Subretinal Deposits in Central Serous Chorioretinopathy.” Archives of Ophthalmology, 120(1), 2002 Jan.
46. “CHAMPS’ Study Group: MRI Predictives of Early Conversion to Clinically Definite MS in the CHAMPS’ Placebo Group.” Neurology 59(7):998-1005, 2002 Oct.
47. Lesser R.L. “Optic Neuritis and Multiple Sclerosis.” Multiple Sclerosis Quarterly Report. Publication of the Eastern Paralyzed Veterans Association and the CMSC/North American Research Committee on MS. Volume 21(3):8-11, Fall 2002.
48. Monsul N.T., Patwa H.S., Knorr A.M., Lesser R.L., Goldstein J.M. “The Effect of Prednisone on the Progression from Ocular to Generalized Myasthenia Gravis.” Journal of the Neurological Sciences, 217:131-133, 2003.
49. Lesser R.L. “Spirochetes and the Spirochetoses.” Walsh & Hoyt’s Clinical Neuro-Ophthalmology, Sixth Edition, Chapter 56., 3077-3114. Editors: Miller NR and Newman NJ. Publisher: Lippincott Williams & Wilkins, 2005.
50. Newman N.J., Biousse V., David R., Bhatti M.T., Hamilton S.R., Farris B.K., Lesser R.L., et al. “Prophylaxis for Second Eye Involvement in Leber’s Hereditary Optic Neuropathy: A Multicenter Trial of Topical Brimonidine Purite.” American Journal of Ophthalmology, 140(3):407-415, 2005 Sept.
51. Klein J.P., Kostina-O’Neil Y., Lesser R.L. “Neuro-ophthalmologic Presentations of Hemicrania Continua.” American Journal of Ophthalmology, 141(1):88-92, 2006 Jan.
52. Newman N.J., Biousse V., Newman S.A., Bhatti M.T., Hamilton S.R., Farris B.K., Lesser R.L., Turbin R.E. “Progression of Visual Field Defects in Leber’s Hereditary Optic Neuropathy: Experience of the LHON Treatment Trial.” American Journal of Ophthalmology, 141(6):1061-1067, 2006 June.
53. Bi W.L., Baehring J.M., Lesser R.L. “Diagnosis of Mitochondrial Encephalomyopathy with Lactic Acidosis and Stroke-Like Episodes.” Journal of Neuro-Ophthalmology, 26(4):251-256, 2006 Dec.
54. Kostina-O’Neil Y., Jirawuthiworavong G.V., Podell D.N. Lesser R.L. “Choroidal and Optic Nerve Infarction in Hepatitis C-Associated Polyarteritis Nodosa.” Journal of Neuro-Ophthalmology, 2007 Sept.
55. Weber E.D., Colyer M. H., Lesser R. L., “Subramanian P.S. Posterior Ischemic Optic Neuropathy After Minimally Invasive Prostatectomy.” Journal of Neuro-Ophthalmology, 27(4):285-287, 2007 Dec.
56. Lesser R.L. Obituary, Rufus Howard, M.D. Archives of Ophthalmology, 126(3):442, 2008 Mar.
57. Silbert J.E., Rudich D.S., Wasserman E., Lesser, R.L. “Recurrent Visual Loss After Endoscopic Sinus Surgery.” Ophthalmic Plastic and Reconstructive Surgery, 24(2):150-152, 2008 Mar/April.
58. Lesser R.L. “How Do You Deal With Nonorganic Visual Loss?” Curbside Consultation in Neuro-Ophthalmology: 49 Clinical Questions. Editors: Andrew G. Lee and Lanning Kline. Publisher: Slack, Inc., 2008.
59. Seth R.K., Kornmehl E.W., Lesser, R.L. Lyme Disease, Microbiology Section. Duane’s Foundations of Clinical Ophthalmology, 2008, Volume 2, Chapter 75. Editors: William Tasman and Edward Jaeger. Publisher: Lippincott Williams & Wilkins.
60. Barbazetto I.A., Lesser R.L., Tom D., Freund K.B. “Diffuse Unilateral Subacute Neuroretinitis Masquerading as a White Dot Syndrome.” British Journal of Ophthalmology, 93(5):574-6, 2009 May.
61. Rudich D.S., Lesser R.L. “See-Saw Nystagmus in a Patient with Septo-Optic Dysplasia.” Journal of Neuro-Ophthalmology, 29(3):251-252, 2009 Sept.
62. Lin J.L., Lesser R.L. “When Night Falls Fast.” EyeNet, 14(8):51-52, 2009 Sept.
63. Lesser R.L., Knisely J.P.S., Wang S.L., Yu J.B., Kupersmith M.J. “Long Term Response to Fractionated Radiotherapy of Presumed Optic Nerve Sheath Meningioma.” British Journal of Ophthalmology, 94(5):559-63, 2010 May.
64. Giacometti J.N., Lesser R.L. “The Patient Who Presented With a Disc Dilemma.” EyeNet, 53-54, September 2011.
65. Prescott C.R., Hasbani J., Levada A.J., Silbert J.E., Winterkorn J.M.S., Lesser R.L. “Ocular Motor Dysfunction in Parry-Romberg Syndrome: Four Cases.” Journal of Pediatric Ophthalmology & Strabismus, 42:e63-6, 2011 Dec.
66. Prescott C.R., Sklar C.A., Lesser R.L., Adelman R.A. “Is Intravitreal Bevacizumab an Effective Treatment Option for Non-Arteritic Anterior Ischemic Optic Neuropathy?” J Neuro-Ophthalmology, 32(1):51-3, 2012 Mar.
67. Vaphiades M., Bhatti T., Lesser R.L. “Ocular Myasthenia Gravis.” Current Opinion in Ophthalmology, 23:6, 537-542. 2012 Aug.
68. Mohsenin A., Lesser R.L. “The Girl Who Was Bugged By Her Sight.” EyeNet, October 2012.
69. El Rassi E., De la Garze A., Lesser R.L., Levin F., Moreau A., Paul S., Servat J., Shield D.R., Silbert, J.E., Turbin, R.E. “Periocular Necrotizing Fasciitis Causing Blindness.” JAMA Ophthalmology, 131.9: 1225-7. 2013 Sept.
70. “The NORDIC Idiopathic Intracranial Hypertension Study: Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss, The Idiopathic Intracranial Hypertension Treatment Trial.” JAMA, 311.16, 2014 Apr.
71. “Editorial: Acetazolamide for Pseudotumor Cerebri, Evidence From the NORDIC Trial.” JAMA, 311.16, 2014 Apr.
72. “Editorial: Idiopathic Intracranial Hypertension, Important Questions Answered with More to Come.” JAMA Neurology. Published online 2014 Apr.
73. “Baseline Visual Field Findings in the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).” IOVS., IOVS-14-14243, 2014 April 29.
74. “The Idiopathic Intracranial Hypertension Treatment Trial, Clinical Profile at Baseline.” JAMA Neurology, 71.6: 693-701. 2014 June.
75. “IIHTT Letter and Reply.” JAMA Neurology, 71.10: 693-701. 2014 Oct.
76. Campbell et al. “Acute Nonarteric Anterior Ischemic Optic Neuropathy & Exposure to Phosphodiesterase Type 5 Inhibitors.” J Sex Med, 2014 Oct.
77. Kupersmith M.K. et al: “Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial, Part I: Quality Control, Comparisons, and Variability.” IOVS, 55.12 8181 – IOVS.14-414960. 2014 Dec.
78. Kupersmith M.K. et al: “Baseline OCT Measurements in the Idiopathic Intracranial Hypertension Treatment Trial, Part II: Correlations and Relationship to Clinical Features.” IOVS. 55.12 8174 – IOVS.14-14961. 2014 Dec.
79. Friedman et al. “The Idiopathic Intracranial Hypertension Treatment Trial: Design Considerations and Methods.” J Neuro-Ophthalmology, 34:107-117. 2014.
80. Kavoussi S.C., Lesser R.L. “Genetic Anticipation in Familial Neuromyelitis Optica: Case and Literature Review.” Connecticut Medicine, 79.4:343-5, 2015 Apr.
81. Kupersmith M.K. et al: “Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.” IOVS, 56.5: 3298. 2015 May.
82. Yun S.H., Lavin P., Schatz M., Lesser R.L. “Topiramate Induced Palinopsia: A Case Series and Review of Literature.” Journal of Neuro-Ophthalmology, 35.2: 148-51. 2015 June.
83. IIHTT Study Group, “Quality of Life in Idiopathic Intracranial Hypertension at Diagnosis.” American Academy of Neurology, 2015 June.
84. Nguyen A., Resor L., Lesser R.L. “Diplopia After a Sinus Infection.” JAMA Ophthalmology, 133.7:845-6, 2015 Jul.
85. Nickerson T.E., Oliveira C.R., Lesser R.L., Andiman W.A. “Macular Star and Central Visual Loss: Two Pediatric Cases.” Clinical Pediatrics, 2015 Aug.
86. Kupersmith M.K. et al: “Retinal and Choroidal Folds in Papilledema.” IOVS, 56.10: 5671. 2015 Sept.
87. “Risk Factors for Poor Visual Outcome in Patients with Idiopathic Intracranial Hypertension.” Neurology 85. 2015 Sept.
88. Lesser R.L. et al. “Papilledema Outcomes From the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.” Ophthalmology, 122,9: 1939-45. 2015 Sept.
89. Golas L. et al. “Varicella Zoster Virus in Ischemic Optic Neuropathy.” Ophthalmology, 122:10, 2142-5. 2015 Oct.
90. Lesser R.L., Silbert J.E., Carlson E., Rudich D.S., Yun S.H., Liebling A., Moeckel G.W. “Antiphospholipid Antibody Syndrome: Raised Intracranial Pressure Without Cerebral Venous Sinus Thrombosis.” J Neuro-Ophthalmol, 35.4. 2015 Dec.
91. Ten Hove et al. “Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.” J Neuro-Ophthalmol, 0:1-7. 2015.
92. Cello et al. “Factors Affecting Visual Field Outcomes in the Idiopathic Intracranial Hypertension Treatment Trial.” J Neuro-Ophthalmol, 0:1-7. 2015.
93. “Semi-Automated 2D Bruch’s Membrane Shape Analysis in Papilledema Using Spectral-Domain Optical Coherence Tomography.” Medical Imaging 2015: Biomedical Applications in Molecular, Structural, and Functional Imaging. Editors: Barjor Gimi and Robert C. Molthen. Proc. of SPIE Vol. 9417, 941721.
94. “’Paton’s Folds’ Revisited: Peripapillary Wrinkles, Folds and Creases in Papilledema.” Ophthalmology , 2015.
95. “CSF Pressure, Papilledema Grade, and Response to Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.” J Neurol, DOI 10.1007/s00415-015-7838-9.
96. Lesser R.L. “How Do You Deal with Nonorganic Visual Loss?” Curbside Consultation in Neuro-Ophthalmology: 49 Clinical Questions, Second Edition. P. 177-82. Editors: Andrew G. Lee and Lanning Kline. Publisher: Slack, Inc., 2015.
97. IIHTT Study Group, Beck: “A Long Time Coming but Worth the Wait.” J Neuro-Ophthalmol, 36: 1-3. 2016
98. Sibony P.A., Kupersmith M.J., Lesser R.L. “’Paton’s Fold’s’ Revisited: Peripapillary Wrinkles, Folds, and Creases in Papilledema.” Ophthalmology 123.6: 1397-9. 2016 June.
99. IIHTT Study Group, “A 6-month Telephone-based Weight Loss Intervention in Overweight and Obese Subjects with Idiopathic Intracranial Hypertension.” Obesity Science & Practice, DOI: 10.1002/osp4.34, 2016 June.
100. IIHTT Study Group, “Quality of Life at 6 Months in the Idiopathic Intracranial Hypertension Treatment Trial.” American Academy of Neurology, Vol. 87 no. 18 1871-1877, 2016, Nov.
101. Parikh R. , Materin M., Lesser R.L., Baehring J., Sznol M., Galvin J., “A 71 Year Old Woman with Decreased Vision, Nyctalopia, and Peripheral Vision Loss.” Digital Journal of Ophthalmology 22.4: 85-90 2016 Dec., published on-line 2016 Dec 31. doi: 10.5693/djo.02.2016.06.001
102. IIHTT Study Group, “Optic Disc Hemorrhages at Baseline as a Risk Factor for Poor Outcome in the Idiopathic Intracranial Hypertension Treatment Trial.” Wall M., Thurtell Matthew J., British Journal of Ophthalmology, 10.1136/bjophthalmol-2016-309852, 2017 Jan.
103. Mark Kupersmith et al. “The Effect of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.” American Journal of Ophthalmology 176.C: 77-86. 2017 Apr.
104. Michael Wall et al. “The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes from Months 6-12.” American Journal of Ophthalmology 176.C: 102-7. 2017 Apr.
105. Libien J., IIHTT Study Group, “Role of Vitamin A Metabolism in IIH” Results from the Idiopathic Intracranial Hypertension Treatment Trial. Journal of Neurological Sciences 372 78-84, 2017.
106. IIHTT Study Group, “Headache in Idiopathic Intracranial Hypertension” Findings from the Idiopathic Intracranial Hypertension Treatment Trial. Journal of Head and Face Pain, ISSN 0017-8748, Headache DOI: 10.111/head.13153, 2017
107. Zhang L.Y., Zhang J., Kim R.K., Matthews J.L., Rudich D.S., Greer D.M., Lesser R.L., Amin H. Risk of Acute Ischemic Stroke In Patients With Monocular Vision Loss of Vascular Etiology. Journal of Neuro-Ophthalmology; 0:1-6 doi: 10.1097/WNO.0000000000000613, Volume 38(3), Sept. 2018, p 328-333
108. Li E, Howard M.A., Vining E.M., Becker R.D., Silbert J., Lesser R.L., Visual Prognosis in Compressive Optic Neuropathy Secondary to Sphenoid Sinus Mucocele: A Systematic Review. ORBIT 2018 Aug;37(4):280-286. , doi: 10.1080/01676830.2017.1423087. Epub 2018 Jan 5.
109. Li E., Kostina Y., Lesser R.L., “New Ophthalmoplegia and Recurrent Ptosis After Ptosis Repair Surgery.” Journal of the American Medical Association of Ophthalmology 1;136(8):952-953 2018, Aug.
110. Pandit R., Paris L., Rudich DS., Lesser R.L., Kupersmith MJ., Miller NR., “Long-term Efficacy of Fractionated Conformal Radiotherapy for the Management of Primary Optic Nerve Sheath Meningioma.” British Journal of Ophthalmology 313135.RI, 2018, Dec.
111. Markus Kuehn M., Lesser R.L., et al, “Genetic Survey of Adult-Onset Idiopathic Intracranial Hypertension.” Journal of Neuro- Ophthalmology 2019, volume 39, page #50 to #55.
112. Li Emily, Emmanuele Valentina, Testa Francine, De Araujo Martins Moreno Christiane, Hirano Michio, Lesser R.L., “Novel Mitochondrial Translation Optimizer-1 Mutation as a Cause of Hereditary Optic Neuropathy”. Journal of Neuro-Ophthalmology 2020 Sept; 40(3):406-410.